Selective resolution of bulimic symptoms and increased suicidal behaviour in an adolescent during fluoxetine treatment

Author: Agnes Ayton

Source: International Journal of Psychiatry in Clinical Practice, Volume 7, Number 3, September 2003 , pp. 213-216(4)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $27.39 plus tax (Refund Policy)

Abstract:

The case of a 15-year-old girl is reported, who suffered from depression and comorbid bulimia nervosa. Her suicidal behaviour worsened with parallel improvement of bulimic symptoms during fluoxetine treatment. These symptoms reversed after the medication was changed to mirtazapine and quetiapine. The small dose of quetiapine was used as an adjunct to the antidepressant treatment, and it resulted in dramatic improvement of mood, cessation of suicidal ideation and return of normal psychosocial functioning. It is suggested that the anti-bulimic effect of fluoxetine is independent of the antidepressant effect. Worsening of suicidal symptoms during fluoxetine treatment warrants a change of antidepressant. Qutiapine may be useful as an adjunct to antidepressants in the management of treatment resistant depression.

Keywords: adolescence; depression; fluoxetine; mirtazapine; quetiapine

Document Type: Research article

DOI: http://dx.doi.org/10.1080/13651500310001554

Publication date: 2003-09-01

More about this publication?
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page